- Home
- VERO vs SCNI Comparison
VERO vs SCNI Comparison
Compare VERO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- SCNI
- Stock Information
- Founded
- VERO N/A
- SCNI 2003
- Country
- VERO Canada
- SCNI Israel
- Employees
- VERO N/A
- SCNI N/A
- Industry
- VERO Medical/Dental Instruments
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VERO Health Care
- SCNI Health Care
- Exchange
- VERO Nasdaq
- SCNI Nasdaq
- Market Cap
- VERO 4.0M
- SCNI 4.6M
- IPO Year
- VERO N/A
- SCNI N/A
- Fundamental
- Price
- VERO $1.90
- SCNI $0.93
- Analyst Decision
- VERO
- SCNI
- Analyst Count
- VERO 0
- SCNI 0
- Target Price
- VERO N/A
- SCNI N/A
- AVG Volume (30 Days)
- VERO 1.8M
- SCNI 63.0K
- Earning Date
- VERO 11-13-2025
- SCNI 11-24-2025
- Dividend Yield
- VERO N/A
- SCNI N/A
- EPS Growth
- VERO N/A
- SCNI N/A
- EPS
- VERO N/A
- SCNI 0.26
- Revenue
- VERO $58,876,000.00
- SCNI $1,147,000.00
- Revenue This Year
- VERO N/A
- SCNI N/A
- Revenue Next Year
- VERO $10.00
- SCNI N/A
- P/E Ratio
- VERO N/A
- SCNI $3.65
- Revenue Growth
- VERO N/A
- SCNI 303.87
- 52 Week Low
- VERO $1.65
- SCNI $0.89
- 52 Week High
- VERO $14.50
- SCNI $6.18
- Technical
- Relative Strength Index (RSI)
- VERO 41.67
- SCNI 31.20
- Support Level
- VERO $1.65
- SCNI $0.89
- Resistance Level
- VERO $3.02
- SCNI $1.07
- Average True Range (ATR)
- VERO 0.22
- SCNI 0.12
- MACD
- VERO -0.03
- SCNI -0.02
- Stochastic Oscillator
- VERO 16.42
- SCNI 12.52
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.